| Common Stock |
4,228,589 |
$63,306,629 |
$14.97 |
24 Oct 2022 |
Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned |
|
|
| Common Stock |
4,124,375 |
$61,746,431 |
$14.97 |
24 Oct 2022 |
F-Prime Capital Partners Life Sciences Fund VI LP |
|
|
| Common Stock |
109,982 |
$1,646,552 |
$14.97 |
24 Oct 2022 |
F-Prime Capital Partners Life Sciences Advisors Fund VI LP |
|
|
| Series A Convertible Preferred Stock |
0 |
|
|
24 Oct 2022 |
Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned |
Common Stock |
|
| Series A Convertible Preferred Stock |
0 |
|
|
24 Oct 2022 |
F-Prime Capital Partners Life Sciences Advisors Fund VI LP |
Common Stock |
|
| Series A Convertible Preferred Stock |
0 |
|
|
24 Oct 2022 |
F-Prime Capital Partners Life Sciences Fund VI LP |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
24 Oct 2022 |
Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
24 Oct 2022 |
F-Prime Capital Partners Life Sciences Advisors Fund VI LP |
Common Stock |
|